Insulin vials to be fully produced in Algeria

 
 
 
CONSTANTINE- Insulin vials, previously imported from abroad, will be henceforth fully produced in Algeria thanks to the start, as of this Sunday, of the production of this medicine by the Unit of Saidal in Constantine, director of the production plant of this public group Dr. Feryal Kherrab.
 
It is a total “production and not only a packaging or filling,” she affirmed in an interview with APS, stressing the importance of the operation in the strengthening of the national health sovereignty, notably through the reduction of the import bill.
 
Constantine’s Saidal Unit will produce, as of 19 March 2023, a quantity of one million units of fast-acting human insulin used in hospitals (in bottles), said Dr. Kherrab, underlining that this figure (1 million sales units) concerns the production fixed for the current year.  
 
The volume of production will be then fixed according to the market’s needs, according to the official who affirmed that Saidal has all the necessary means to meet all the expressed demands.  
 
This medicine will be produced by qualified and trained Algerian staff, said Dr. Kherrab, pointing out that the team in charge of producing insulin in vials has benefitted, in early February, from an additional training session in Russia on quality control.